is the most common type of cancer prevailing across the globe. According to WHO, lung cancer is expected to be more prominent in the underdeveloped world due to an increase in the use of tobacco products; tobacco is the primary cause of around 80% of all lung cancers. According to WHO, lung cancer cases in developing economies is expected to reach 2,530,820 by 2025. Globally increasing awareness about cancers and about available treatments coupled with favourable reimbursement scenario in the developed countries favors the market for lung cancer surgery. These two factors are expected to be the key growth drivers for the lung cancer surgery market during the period of study.
Geographically North America dominated global lung cancer surgery market
driven by best in the class healthcare infrastructure, advanced facilities and awareness and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for lung cancer surgery market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.
This report identifies the global lung cancer surgery market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global lung cancer surgery market.This report segments global lung cancer surgery market on the basis of by type, end-user and regional market as follows:
This report identifies all the major companies operating in the lung cancer surgery market. Some of the major companies’ profiles in detail are as follows:
- Lung Cancer Surgery Market, By Type: Thoracotomy, Minimally Invasive Procedures (Video-Assisted Thoracoscopic Surgery (Vats), Robotic Surgery)
- Lung Cancer Surgery Market, End-User: Hospitals, Adult Lung Cancer Surgery Centers, Ambulatory Surgical Centers
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
- Siemens Healthcare
- Richard Wolf Gmbh
- Olympus Cor
- Neomend Inc.
- Ethicon Endo-Surgery Inc.